期刊文献+

GRIN1基因与双相情感障碍的关联研究 被引量:1

下载PDF
导出
摘要 目的探讨谷氨酸受体离子化NMDA1受体基因(GRIN1)在双相情感障碍(bipolar disorder,BD)的发病机制中是否发挥作用。方法收集BD患者EDTA-K2抗凝静脉血70份,健康体检人员EDTA-K2抗凝静脉血100份,分离DNA,从GRIN1基因调控区G1001C(rs11146020)上取1个SNP位点(-855G/C),采用PCR和RFLP分析技术,对其进行单核苷酸多态性分析。结果两组中基因型GC和CC携带者患BD的可能性分别是GG基因型的3.0和3.5倍。结论 GRIN1基因调控区上的rs11146020与双相情感障碍发病相关,该GRIN1基因是双相情感障碍的易感基因之一。
出处 《广东医学》 CAS CSCD 北大核心 2010年第12期1588-1589,共2页 Guangdong Medical Journal
  • 相关文献

参考文献10

  • 1WEISSMAN M M,LEAF P J,TISCHLER G L,et al.Affentive disorder in five united states communities[J].Psychol Med,1988,18(3):141-153.
  • 2王金荣,王德平,沈渔笛,张维熙,李淑然,陈昌惠,黄悦勤,涂健,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区情感性精神障碍流行病学调查[J].中华精神科杂志,1998,31(2):75-77. 被引量:62
  • 3OWENS M J,NEMEROFF C B.Role of serotonin in the pathophysiology of depression:focus on the serotonin transporter[J].Clin Chem,1994,40(2):288-295.
  • 4DIEHL D,GERSHON S.The role of dopamine in mood disorders[J].Gompr Psychiatry,1992,33(2):115-120.
  • 5MUNDO E,THARMALINGHAM S,NEVES-PEREIRA M,et al.Evidence that the N-methyl-D-aspartate subunit 1 receptor gene(GRIN1) confers susceptibility to bipolar disorder[J].Molecular Psychiatry,2003,8(2):241-245.
  • 6李忠杰,王保捷,丁梅,庞灏,孙雪菲,杨俊.谷氨酸受体基因单核苷酸多态性与精神分裂症的关联[J].法医学杂志,2008,24(5):369-374. 被引量:6
  • 7BEGNI S,MORASCHI S,BIGNOTTI S,et al.Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia[J].Biol Psychiatry,2003,53(7):617-619.
  • 8ZHAO XINZHI,LI HUAFANG,SHI YONGYONG,et al.Significant Association Between the Genetic Variationsin the 5' end of the N-Methyl-D-Aspartate Receptor Subunit Gene GRIN1 and Schizophrenia[J].Biol Psychiatry,2006,59(8):747-753.
  • 9刘敏,凌四海,李文标,王传跃,陈大方,王刚.BDNF、GRIN1基因与双相情感障碍的关联研究[J].遗传,2007,29(1):41-46. 被引量:8
  • 10MOHN A R,GAINETDINOV R R,CARON M G,et al.Mice with reduced NMDA receptor expression display behaviors related to schizophrenia[J].Cell,1999,98(4):427-436.

二级参考文献33

  • 1Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:381
  • 2张维熙,中华精神科杂志,1998年,31卷,69页
  • 3沈其杰,中国现代神经精神病学发展概况,1995年,247页
  • 4王祖新,精神病学(第3版),1994年,628页
  • 5杨德森,中国精神疾病诊断标准与案例,1989年,502页
  • 6陶国泰,精神病学(第2版),1988年,279页
  • 7Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment[J]. Pharmacol Ther, 2003,97 (2) : 153-179.
  • 8Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia[J]. Am J Psychiatry, 1991,148(10) : 1301-1308.
  • 9Dall'Olio R, Gandolfi O. The NMDA positive modulator D-cycloserine potentiates the neuroleptie activity of D1 and D2 dopamine receptor blockers in the rat [J]. Psychopharmacology (Berl), 1993,110 (1-2) : 165-168.
  • 10Goff DC, Tsai G, Manoach DS, et al. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia[J]. Am J Psychiatry, 1995,152(8) :1213-1215.

共引文献70

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部